Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMPLF.L Regulatory News (MPLF)

  • There is currently no data for MPLF

MPLF Revolving Credit Facility

21 Nov 2019 07:00

RNS Number : 1430U
Marble Point Loan Financing Limited
21 November 2019
 

NOT FOR RELEASE, DISTRIBUTION OR PUBLICATION TO ANY PERSON LOCATED OR RESIDENT IN ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF APPLICABLE LAW. THIS ANNOUNCEMENT IS FOR INFORMATION PURPOSES ONLY AND IT IS NOT AN OFFER TO PURCHASE, OR A SOLICITATION OF AN OFFER TO SELL, ANY NOTES OR OTHER SECURITIES.

 

21 NOVEMBER 2019

 

MARBLE POINT LOAN FINANCING LIMITED

NEW REVOLVING CREDIT FACILITY

Marble Point Loan Financing Limited (the "Company") has closed a credit agreement with City National Bank establishing a revolving credit facility of up to US$12,500,000 on 20 November 2019. The facility will provide the Company with flexible capital for acquiring investments in accordance with its investment objective and strategy and for general corporate purposes.

"We are pleased that the Company has entered into the revolving credit facility and believe it is beneficial to shareholders in that this facility will enable the Company to make further investments and continue to seek attractive risk-adjusted returns for its shareholders," said Thomas Shandell, CEO and CIO of Marble Point Credit Management LLC, the Company's investment manager.

Enquiries:

Marble Point Loan Financing Limited

Investor Relations

www.mplflimited.com 

P: +44 (0) 20 7259 1500

E: ir@mplflimited.com 

Corporate Broker:

Stifel Nicolaus Europe Limited

P: +44 (0) 20 7710 7600

 

ABOUT MARBLE POINT LOAN FINANCING LIMITED

Marble Point Loan Financing Limited (the "Company") is a Guernsey-domiciled closed-ended investment company with its ordinary shares admitted to trading on the Specialist Fund Segment of the Main Market of the London Stock Exchange (ticker: MPLF.LN). The Company is invested in a diversified portfolio of US dollar denominated, broadly syndicated floating rate senior secured corporate loans via CLOs and related vehicles managed by Marble Point Credit Management LLC ("Marble Point") or its affiliates. Marble Point is an investment adviser registered with the U.S. Securities and Exchange Commission. Registration does not imply a certain level of skill or training.

ABOUT CITY NATIONAL

With $56.2 billion in assets, City National Bank provides banking, investment and trust services through 70 offices, including 19 full-service regional centers, in Southern California, the San Francisco Bay Area, Nevada, New York City, Nashville, Atlanta, Minneapolis and Washington, D.C. In addition, the company and its investment affiliates manage or administer $78.0 billion in client investment assets. 

City National is a subsidiary of Royal Bank of Canada (RBC), one of North America's leading diversified financial services companies. RBC serves more than 16 million personal, business, public sector and institutional clients through offices in Canada, the United States and 34 other countries.

For more information about City National, visit the company's website at cnb.com.

 

Important Information

This document has been issued by the Company and is the sole responsibility of the Company. This document and the information and views included herein do not constitute investment advice, or a recommendation or an offer to enter into any transaction with the Company or any of its affiliates. Each recipient of this document should make such investigations as it deems necessary to arrive at an independent evaluation of any investment and should consult its own legal counsel and financial, actuarial, accounting, regulatory and tax advisers to evaluate any such investment. This document is provided for informational purposes only, does not constitute an offer to sell any Notes or Shares issued by the Company or a solicitation of an offer to purchase any such Notes or Shares in the United States, Australia, Canada, the Republic of South Africa, Japan or any other jurisdiction, and is not a prospectus. This document may not be relied upon and should not be used for the purpose of making any investment decision.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
IODEADFEALKNFAF
Date   Source Headline
17th Sep 20244:15 pmRNSQ2 24 UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS
10th Sep 20244:21 pmRNSDirectorate Change
27th Aug 20246:00 pmRNSNet Asset Value & Publication of Monthly Report
23rd Aug 20244:09 pmRNSLiquidating Share Class Distribution
14th Aug 20244:11 pmRNSNotice of Cancellation of Admission to Trading
9th Aug 20244:16 pmRNSHolding(s) in Company
7th Aug 20245:04 pmRNSHolding(s) in Company
7th Aug 20245:03 pmRNSHolding(s) in Company
30th Jul 20247:00 amRNSDoc re. Key Information Document
29th Jul 20247:00 amRNSNet Asset Value & Publication of Monthly Report
25th Jul 20245:57 pmRNSConversion of Securities
18th Jul 20245:52 pmRNSSterling Dividend Amount
3rd Jul 20244:27 pmRNSDoc re. LSC Elections
27th Jun 20247:11 amRNSDividend Declaration
26th Jun 20247:00 amRNS1st Quarter Results
25th Jun 20247:00 amRNSNet Asset Value & Publication of Monthly Report
21st Jun 20241:13 pmRNSNotice of Results - 20 June 2024 EGM
21st Jun 20247:00 amRNSTotal Voting Rights - Class B Shares
24th May 20247:00 amRNSNotice of Extraordinary General Meeting
22nd May 20244:23 pmRNSLiquidating Share Class Distribution
21st May 20247:00 amRNSNet Asset Value & Publication of Monthly Report
25th Apr 20244:51 pmRNSSterling Dividend Amount
23rd Apr 20247:00 amRNSNet Asset Value & Publication of Monthly Report
12th Apr 20245:01 pmRNSAnnual Financial Report
4th Apr 20247:00 amRNSDividend Declaration
25th Mar 20246:00 pmRNSNet Asset Value & Publication of Monthly Report
13th Mar 20247:00 amRNSIssue of Equity from Treasury - Amending RNS 3485F
1st Mar 20245:47 pmRNSMPLF Issue of Equity from Treasury
27th Feb 20247:00 amRNSNet Asset Value & Publication of Monthly Report
23rd Feb 20244:33 pmRNSNotice of Results of Extraordinary General Meeting
20th Feb 20247:00 amRNSLiquidating Share Class Distribution
29th Jan 20244:06 pmRNSCarey Commercial Limited – Change of Name
29th Jan 20247:00 amRNSNet Asset Value & Publication of Monthly Report
26th Jan 20246:00 pmRNSNotice of GM
18th Jan 20244:30 pmRNSSterling Dividend Amount
27th Dec 20237:00 amRNSNet Asset Value & Publication of Monthly Report
27th Dec 20237:00 amRNSDividend Declaration
28th Nov 20236:30 pmRNSNet Asset Value & Publication of Monthly Report
21st Nov 20237:00 amRNS3rd Quarter Results
17th Nov 20236:00 pmRNSLiquidating Share Class Distribution
17th Nov 20237:00 amRNSResults of Annual General Meeting (“AGM”)
30th Oct 20237:00 amRNSNotice of Annual General Meeting (“AGM”)
24th Oct 20236:00 pmRNSNet Asset Value & Publication of Monthly Report
20th Oct 20235:02 pmRNSDividend Declaration
28th Sep 20237:00 amRNSDividend Declaration
25th Sep 20237:00 amRNSNet Asset Value & Publication of Monthly Report
13th Sep 20236:00 pmRNSHalf-Yearly Report
23rd Aug 20237:00 amRNSNet Asset Value & Publication of Monthly Report
18th Aug 20234:36 pmRNSDistribution Announcement
27th Jul 20233:55 pmRNSMPLF - Key Information Document (KID)

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.